Glenmark Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
GLENMARK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Glenmark Pharmaceuticals has informed stock exchanges that its Board of Directors will meet on Friday, September 26, 2025, to consider and approve payment of an interim dividend, if any, on equity shares for the financial year 2025-26. The company has set Tuesday, September 30, 2025 as the record date to determine shareholders eligible for the dividend, if declared. Additionally, the trading window for designated persons has been closed and will remain so until Sunday, September 28, 2025, in line with SEBI's insider trading regulations.
Investors should watch for the board meeting outcome on September 26 — if an interim dividend is declared, shareholders on record by September 30 will be eligible. The trading window closure signals that the company is in a quiet period ahead of the announcement, which is standard practice.